The U.S. is one of the largest and most mature markets for pharyngitis tablets, driven by a high prevalence of sore throat and upper respiratory infections, particularly during the cold and flu season. Strong demand for both prescription treatments and over-the-counter lozenges and tablets is supported by widespread pharmacy and retail access, high consumer awareness, and a well-established...